Atara Biotherapeutics Says Carol Gallagher To Replace Ron Renaud As Chair Of The Board Of Directors

RTTNews | 864天前
Atara Biotherapeutics Says Carol Gallagher To Replace Ron Renaud As Chair Of The Board Of Directors

(RTTNews) - Atara Biotherapeutics, Inc. (ATRA) announced Monday that Carol Gallagher will assume the role of Chair of the Board of Directors, replacing Ron Renaud, who is stepping down to focus on his new position as Managing Director at Bain Capital Life Sciences.

Gallagher is a venture partner in the life sciences practice of New Enterprise Associates and an experienced public company director. She has served as a Director at Atara since 2013 and as a member of both the Compensation and Nominating and Corporate Governance Committees.

Gallagher was formerly the President and CEO of Calistoga Pharmaceuticals and has held commercial and drug development roles within Eli Lilly, Amgen, Agouron, Pfizer and Biogen Idec.

Atara also announced that after four years of service, Roy Baynes, has decided to step down from Atara's Board of Directors to pursue other external opportunities following his retirement from Merck.

read more
Atara's Ebvallo Receives European Commission Approval For Adults And Children With EBV+ PTLD

Atara's Ebvallo Receives European Commission Approval For Adults And Children With EBV+ PTLD

Atara Biotherapeutics, Inc. (ATRA) and French healthcare company Pierre Fabre announced Monday that the European Commission (EC) has granted marketing authorization for Ebvallo (tabelecleucel) as a monotherapy for the treatment of adult and pediatric patients two years of age and older with relapsed or refractory Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) who have received at least one prior therapy.
RTTNews | 864天前
Tesla Chair Denies Report Of CEO Search To Replace Elon Musk

Tesla Chair Denies Report Of CEO Search To Replace Elon Musk

Tesla Inc. chair Robyn Denholm has denied a Wall Street Journal report that its board was searching for a replacement for Chief Executive Officer Elon Musk. On the social media platform X, she called the report as "absolutely false." Shares of Tesla had fallen around 3 percent on Wednesday's trading following the news. However, with the denial of the report, the stock is currently gaining.
RTTNews | 51分鐘前
UK Mortgage Approvals Lowest In 8 Months

UK Mortgage Approvals Lowest In 8 Months

UK mortgage approvals decreased to the lowest level in eight months in March despite home buyers rushing to complete the transactions ahead of the rise in stamp duty, official data revealed on Thursday. Mortgage approvals decreased 800 to 64,309 in March, the Bank of England said. Approvals for house purchases, an indicator of future borrowing, decreased for the third straight month.
RTTNews | 1小時44分鐘前
Yen Slides As Bank Of Japan Retains Rate As Expected

Yen Slides As Bank Of Japan Retains Rate As Expected

The Japanese yen weakened against other major currencies in the Asian session on Thursday, after the Bank of Japan left its interest rate unchanged for the second consecutive meeting and downgraded its growth projections citing trade tariff threats.
RTTNews | 4小時43分鐘前
Commodity Currencies Rise Amid Risk-on Mood

Commodity Currencies Rise Amid Risk-on Mood

The commodity currencies such as Australia, the New Zealand and the Canadian dollars strengthened against their major currencies in the Asian session on Thursday amid increased risk-on mood, as traders booked some profits after the recent upside in markets and a report showing the U.S. economy unexpectedly shrank in the first three months of 2025 generated some optimism about the outlook for interest rates.
RTTNews | 4小時58分鐘前
Yen Slides Against Majors

Yen Slides Against Majors

The Japanese yen strengthened against other major currencies in the Asian session on Thursday.
RTTNews | 6小時8分鐘前